A recent blog post written by attorney Dara Katcher Levy describes a citizen petition that was recently submitted by seven pharmaceutical companies requesting more clarification regarding off-label use manufacturer-communications. Specifically, as described by Levy, the companies wrote the petition to request more hard-fast rules and information regarding the following four types of off-label use manufacturer-communications:
Levy goes on to explain that pharmaceutical companies are looking for specified rules (as opposed to full-scale guidance documents) and for the clarification of various confusions related to off-label use manufacturer-communications.
We use cookies to make interactions with our website more meaningful, to better understand how people use the site, and to tailor advertising. You can read more about how we use cookies here.